CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
163 hedge funds and large institutions have $371M invested in Clovis Oncology, Inc. in 2021 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less call options, than puts
Call options by funds: $19.3M | Put options by funds: $33.8M
Holders
163
Holding in Top 10
1
Calls
$19.3M
Puts
$33.8M
Top Buyers
| 1 | +$9.38M | |
| 2 | +$8.67M | |
| 3 | +$6.83M | |
| 4 |
Citigroup
New York
|
+$4.67M |
| 5 |
Rafferty Asset Management
New York
|
+$2.59M |
Top Sellers
| 1 | -$32.6M | |
| 2 | -$12.3M | |
| 3 | -$10.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.65M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.04M |